Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 2

Smoking and smoking cessation in Latin America: a review of the current situation and available treatments

Authors Fernando Müller, Luis Wehbe

Published 6 June 2008 Volume 2008:3(2) Pages 285—293


Fernando Müller1, Luis Wehbe2

1Universidad Nacional de Buenos Aires and Proyecto Médico Especialista en Dejar de Fumar, Buenos Aires, Argentina; 2Ave Pulmo Smoking Cessation Institute, Mar del Plata, Argentina

Abstract: Tobacco smoking is a growing problem throughout Latin American countries, especially in underdeveloped countries where poverty and lack of education about the dangers of smoking may make people more susceptible to becoming smokers. Moreover, the economies of many Latin American countries have become dependent on the production of tobacco. Furthermore, because of the associated promotion of tobacco, smoking has integrated into many Latin American cultures. Nevertheless, the harmful health effects of tobacco use are well documented, including greatly increased risks of developing chronic obstructive pulmonary disease, cardiovascular disease, and many forms of cancer. The medical costs associated with treating these diseases far outweigh the economic benefits of producing and selling this deadly crop. To control the tobacco pandemic in Latin American countries, nicotine addiction must be recognized and treated as a disease. Governments, both national and local, need to be more involved in enacting anti-smoking policies such as higher tobacco taxation, control of illegal tobacco smuggling, and reimbursement of medical smoking cessation interventions. The training of health professions in the area of nicotine addiction must also be improved, so that they may better assist smokers in their quit attempts and advise patients on, and prescribe, effective smoking cessation pharmacotherapies.

Keywords: smoking, smoking cessation, tobacco, Latin America

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer

Zhao Q, Qian S, Zhu L, Qu XD, Zhang W, Yan ZP, Cheng JM, Liu QX, Liu R, Wang JH

OncoTargets and Therapy 2015, 8:595-600

Published Date: 9 March 2015

Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice

Melariri P, Kalombo L, Nkuna P, Dube A, Hayeshi R, Ogutu B, Gibhard L, deKock C, Smith P, Wiesner L, Swai H

International Journal of Nanomedicine 2015, 10:1493-1503

Published Date: 20 February 2015

Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection

Yang Z, Chen M, Yang M, Chen J, Fang W, Xu P

International Journal of Nanomedicine 2014, 9:327-336

Published Date: 6 January 2014

Bismuth oxide aqueous colloidal nanoparticles inhibit Candida albicans growth and biofilm formation

Hernandez-Delgadillo R, Velasco-Arias D, Martinez-Sanmiguel JJ, Diaz D, Zumeta-Dube I, Arevalo-Niño K, Cabral-Romero C

International Journal of Nanomedicine 2013, 8:1645-1652

Published Date: 24 April 2013

Echographic detectability of optoacoustic signals from low-concentration PEG-coated gold nanorods

Conversano F, Soloperto G, Greco A, Ragusa A, Casciaro E, Chiriacò F, Demitri C, Gigli G, Maffezzoli A, Casciaro S

International Journal of Nanomedicine 2012, 7:4373-4389

Published Date: 9 August 2012

Aspirin and clopidogrel resistance: methodological challenges and opportunities

Armen Yuri Gasparyan

Vascular Health and Risk Management 2010, 6:109-112

Published Date: 2 March 2010

SAFA: A new measure to evaluate psychiatric symptoms detected in a sample of children and adolescents affected by eating disorders. Correlations with risk factors

Emilo Franzoni, Morena Monti, Alessandro Pellicciari, Carlo Muratore, Alberto Verrotti, et al

Neuropsychiatric Disease and Treatment 2009, 5:207-214

Published Date: 19 March 2009

A dose-ranging study of tiotropium delivered via Respimat® Soft Mist™ Inhaler or HandiHaler® in COPD patients

Denis Caillaud, Charles Le Merre, Yan Martinat, Bernard Aguilaniu, Demetri Pavia

International Journal of Chronic Obstructive Pulmonary Disease 2007, 2:559-565

Published Date: 15 January 2008